Your browser doesn't support javascript.
loading
Osteoarthritis Bone Marrow Lesions.
Walsh, D A; Sofat, N; Guermazi, A; Hunter, D J.
Afiliação
  • Walsh DA; Professor of Rheumatology, Pain Centre Versus Arthritis, NIHR Nottingham Biomedical Research Centre, Academic Rheumatology, Division of Injury, Inflammation and Recovery, School of Medicine, University of Nottingham Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham, NG5 1PB, Unite
  • Sofat N; Professor of Rheumatology, Institute for Infection and Immunity, St George's University of London, Cranmer Terrace, London, SW17 ORE, United Kingdom; Consultant Rheumatologist, St George's University Hospitals NHS Trust, London, SW17 OPQ, United Kingdom. Electronic address: nsofat@sgul.ac.uk.
  • Guermazi A; Professor of Radiology, Department of Radiology, VA Boston Healthcare System, Boston University School of Medicine, Boston, MA, United States. Electronic address: guermazi@bu.edu.
  • Hunter DJ; Professor of Medicine, Sydney Musculoskeletal Health, Kolling Institute, University of Sydney and Rheumatology Department, Royal North Shore Hospital, Sydney, Australia. Electronic address: david.hunter@sydney.edu.au.
Osteoarthritis Cartilage ; 31(1): 11-17, 2023 01.
Article em En | MEDLINE | ID: mdl-36191832
Assessment and treatment of Bone Marrow Lesions (BMLs) could ultimately make step changes to the lives of people with osteoarthritis (OA). We here review the imaging and pathological characteristics of OA-BMLs, their differential diagnosis and measurement, and cross-sectional and longitudinal associations with pain and OA structural progression. We discuss how biomechanical and cellular factors may contribute to BML pathogenesis, and how pharmacological and non-pharmacological interventions that target BMLs might reduce pain and OA structural progression. We critically appraise semiquantitative and quantitative methods for assessing BMLs, and their potential utilities for identifying people at risk of symptomatic and structural OA progression, and evaluating treatment responses. New interventions that target OA-BMLs should both confirm their importance, and reduce the unacceptable burden of OA.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Ósseas / Doenças das Cartilagens / Osteoartrite do Joelho Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Osteoarthritis Cartilage Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Ósseas / Doenças das Cartilagens / Osteoartrite do Joelho Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Osteoarthritis Cartilage Ano de publicação: 2023 Tipo de documento: Article